Trial Profile
Skeletal Muscle Blood Flow in Becker Muscular Dystrophy
Status:
Discontinued
Phase of Trial:
Phase 0
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Duchenne muscular dystrophy
- Focus Pharmacodynamics
- 10 Jan 2020 Status changed from recruiting to discontinued.
- 08 Mar 2017 The primary drug has changed and phase changed from 0 to phase 1, hence protocol amended.
- 08 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.